Fürst Medical Laboratory has acquired PatoGen
Proud new owner of 100% of the shares will continue to develop PatoGen as the leading provider of preventive and diagnostic analysis to the growing aquaculture industry.
The latest from PatoGen
Proud new owner of 100% of the shares will continue to develop PatoGen as the leading provider of preventive and diagnostic analysis to the growing aquaculture industry.
We have a new analysis available and have expanded our analysis offer for Pasteurella.
In collaboration with a farmer, PatoGen has discovered a novel virus in ballan wrasse hatchlings which is associated with high mortality shortly after hatching. The virus has been named ballan wrasse birnavirus (BWDV).
PatoGen Ltd is excited to announce an expansion in the UK and that we are establishing a laboratory for our preventive and diagnostic services in Oban, Scotland.
PatoGen is now offering an analysis for non-virulent ISAV-HPR0 on gills.
In the fall of 2019 PatoGen launched histology as a new service following a high demand from customers. Now the capacity is increasing, we have hired histopathologist number four and a new innovative report format has been implemented to simplify our customers everyday life. The feedback on the service has been positive.
Because of the ongoing outbreak of COVID-19, PatoGen has implemented measures to secure normal operations at our laboratories.
Swabbing of gills is a gentle sampling method that can also be performed on live fish. PatoGen now offers screening of gill agents with swabs.
PatoSafe Disease Clarification is a tool for quickly clarifying the causes and mortality in production of fish in freshwater and seawater.
PatoGen now offers analysis for PMCV, the virus that causes CMS, complementing the analysis package for salmon and cleaner fish.